首页 | 本学科首页   官方微博 | 高级检索  
     

视网膜母细胞瘤综合治疗的预后及其相关因素
引用本文:路璐,唐松,郭慧,刘桂琴,赵东升. 视网膜母细胞瘤综合治疗的预后及其相关因素[J]. 中华眼视光学与视觉科学杂志, 2017, 19(9): 560-564. DOI: 10.3760/cma.j.issn.1674-845X.2017.09.008
作者姓名:路璐  唐松  郭慧  刘桂琴  赵东升
作者单位:518040,深圳市眼科医院 深圳市眼科学重点实验室 暨南大学附属深圳眼科医院
基金项目:深圳市科创委创新环境建设计划(ZDSY20130402154836214),深圳市科创委重大项目(CXZZ2013051616181591) This study was funded by Shenzhen Science and Technology Innovation Committee Environment Construction Foundation(ZDSY20130402154836214),Shenzhen Science and Technology Innovation Committee Key Research Program(CXZZ2013051616181591)
摘    要:目的:研究视网膜母细胞瘤(RB)患儿综合治疗的预后并探讨其相关临床因素。方法:回顾性系列病例研究。分析在深圳市眼科医院进行综合治疗的65例(92眼)RB患儿的临床资料。综合治疗的方法为以化疗为主联合局部治疗(光凝或冷冻)+眼球摘除治疗。不同结局相关临床因素的比较采用独立样本t检验,其余指标采用Fisher's精准检验。结果:所有RB患儿的总生存率为92%,不同分期生存率差异无统计学意义。所有患儿总的保眼率为51%,E期和其他4期之问保眼率差异均有统计学意义(P<0.01)。高风险D、E期RB患儿共60例,采用化疗联合局部治疗保眼的共42例,D期18例中11例保眼成功,E期24例中4例保眼成功。治疗成功与失败患儿的初诊时间和随访时间差异无统计学意义。根据眼内肿瘤的位置将42例患儿分为3组,分析显示即周边部(包括中周部)与后极部、后极部+周边部保眼率差异有统计学意义(P=0.009、0.021)。42例患儿中4例死亡,均为肿瘤位置处于后极部的患儿,后极部与后极部+周边部2组之间病死率差异有统计学意义( P=0.045)。结论:综合治疗提高了RB患儿的生存率,但患儿的生存率和保眼率与其临床分期及肿瘤所处的位置高度相关。

关 键 词:视网膜母细胞瘤  综合治疗  预后因素  
收稿时间:2017-04-25

Analysis of Prognostic Factors of Comprehensive Treatment on Retinoblastoma
Lu Lu,Song Tang,Hui Guo,Guiqin Liu,Dongsheng Zhao. Analysis of Prognostic Factors of Comprehensive Treatment on Retinoblastoma[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2017, 19(9): 560-564. DOI: 10.3760/cma.j.issn.1674-845X.2017.09.008
Authors:Lu Lu  Song Tang  Hui Guo  Guiqin Liu  Dongsheng Zhao
Affiliation:Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Affiliated Shenzhen Eye Hospital of Jinan University, Shenzhen 518040, China
Abstract:Objective: To characterize the comprehensive treatment of retinoblastoma (RB) and investigate the related clinical factors. Methods: In this retrospective study, clinical datas were analyzed for 65 cases (92 eyes) of childhood RB that received comprehensive treatment, including chemotherapy, local treatment (laser or cryotherapy), and enucleation. Using t-test and Fisher's exact test to analyze the data. Results: The survival rate for the 65 cases was 92%. The eyeballs were preserved in 51% of the children. The rate of eyeball preservation in stage E group was significantly lower than the other four stage groups (P<0.01). Children in stage D group (18 cases) and stage E group (24 cases) were treated with chemotherapy combined with local therapy. The eyeballs were preserved in 11 cases in stage D groups and 4 cases in stage E groups. There were no significant differences in the clinical factors between eyeballs preserved or not children.The patients in stage D and E groups were further divided into three groups according to the location of the tumors in the eye: it showed peripheral retina (including the mid- peripheral retina) group with higher rate of eyeball preservation than the posterior pole retina and the posterior pole retina+peripheral retina group (P=0.009, 0.021). Four of the 42 patients died, all with tumors located in the posterior pole retina (P=0.045 compared to the peripheral retina and to the posterior pole retina+peripheral retina). Conclusions: Compr-ehensive treatment improved the survival and eyeball preservation rate of children with RB. The survival rates and eyeball preservation rates were closely related to the clinical stage.
Keywords:retinoblastoma  comprehensive treatment  prognostic factors
本文献已被 万方数据 等数据库收录!
点击此处可从《中华眼视光学与视觉科学杂志》浏览原始摘要信息
点击此处可从《中华眼视光学与视觉科学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号